Cargando…

The possible of immunotherapy for COVID-19: A systematic review

The novel coronavirus (2019-nCoV) is an emerging pathogen that was first described in late December 2019 and causes a severe respiratory infection in humans. Since the outbreak of COVID-19, international attention has raised to develop treatment and control options such as types of immunotherapies....

Descripción completa

Detalles Bibliográficos
Autores principales: AminJafari, Akram, Ghasemi, Sorayya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128194/
https://www.ncbi.nlm.nih.gov/pubmed/32272396
http://dx.doi.org/10.1016/j.intimp.2020.106455